Showing results (691-700 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|August 26, 2016
Mapping Between the Sydney Asthma Quality of Life Questionnaire (AQLQ-S) and Five Multi-Attribute Utility Instruments (MAUIs)Billingsley Kaambwa, Gang Chen, Julie Ratcliffe, et al.Pharmacoeconomics|January 19, 2026
Development of Cardiovascular Risk Equations in People with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes Based on the SELECT TrialMartin Bøg, Anders Bo Bojesen, Scott Emerson, et al.Pharmacoeconomics|May 5, 2020
Economic Costs of Myasthenia Gravis: A Systematic ReviewErik Landfeldt, Oksana Pogoryelova, Thomas Sejersen, et al.Pharmacoeconomics|November 20, 2022
The Societal Cost of Schizophrenia: An Updated Systematic Review of Cost-of-Illness StudiesClaire Lin, Xiaoyu Zhang, Huajie JinPharmacoeconomics|September 15, 2012
The cost effectiveness of genetic testing for CYP2C19 variants to guide thienopyridine treatment in patients with acute coronary syndromes: a New Zealand evaluationLaura Panattoni, Paul M Brown, Braden Te Ao, et al.Pharmacoeconomics|November 3, 2012
Continuous time simulation and discretized models for cost-effectiveness analysisMarta O Soares, Luísa Canto E CastroPharmacoeconomics|July 28, 2020
Cost-Effectiveness of Cannabidiol Adjunct Therapy versus Usual Care for the Treatment of Seizures in Lennox-Gastaut SyndromeEdward E Neuberger, Josh J Carlson, David L VeenstraPharmacoeconomics|July 23, 2020
Perspective and Costing in Cost-Effectiveness Analysis, 1974-2018David D Kim, Madison C Silver, Natalia Kunst, et al.Pharmacoeconomics|July 14, 2020
External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management InterventionsSandra Lopes, Pierre Johansen, Mark Lamotte, et al.Pharmacoeconomics|August 5, 2020
Cost of Nine Pediatric Infectious Illnesses in Low- and Middle-Income Countries: A Systematic Review of Cost-of-Illness StudiesGatien de Broucker, So Yoon Sim, Logan Brenzel, et al.Pageof 335